Reimbursement Alerts - Med Tech
Subscription service with email alerts about key reimbursement developments for medical devices, in-vitro diagnostic tests and digital technologies in 15 countries in Europe

Get three-month, free, no-obligation trial to understand the value of the service to your organization




This website uses cookies to ensure you get the best experience on our website. By carrying on browsing, you are giving your consent for us to set cookies.

Learn more
This sub-site (services.mtrconsult.com) is no longer updated. Please, proceed to our main web-site to learn about our services (www.mtrconsult.com)
Market access is an actively developing field. Every month and surely every year, multiple changes are happening in the reimbursement systems:

  • Release of new procedure codes
  • Changes in the payment system (DRG and add-on reimbursement)
  • Release of new reimbursement codes
  • Coverage decisions from payors and decision-makers
  • Structural changes in the system (change of stakeholders, responsibilities, new regulations)
  • Release or update of clinical practice guidelines
  • Changes in the innovation funding schemes

For any medical device company, it is a challenge to follow all developments in the markets.

We offer the "Reimbursement Alerts" services, in which our team bi-weekly tracks all developments from more than 46 reimbursement stakeholders in Europe and shares this information with subscribers. This can help you stay up-to-date and ahead of the competition by promptly reacting to key developments in reimbursement systems.

This is a twin service with similar activity on initiated and published health technology assessments, "HTA Alerts – Med Tech".

Key features of the service
More than 120 reimbursement news are reported in Europe every 2 weeks
  • European coverage
    The service includes key reimbursement organizations (payors, decision-makers, DRG administrators, and developers of procedure codes) in Europe. In total, 46 organizations from 15 European countries are monitored
  • All news are classified according to 31 Technology Groups
    The service helps to focus only on technologies of interest (e.g., cardiovascular devices or in-vitro diagnostic tests) and avoid wasting time on not relevant reports
  • Key national organizations are included
    The service focuses on key national organizations and national legislation in each country. Organizations were selected on the basis of an audit of their activity and importance in the reimbursement framework. Regional organizations are not covered at the moment
  • Customized alerts and unlimited number of subscribers
    All reports are customized based on the client's preferences about geographical (you can select only particular countries for monitoring) and technological (e.g., only news for neuromodulation technologies) coverage. The number of enrolled subscribers from one company is unlimited
  • Timely alerts with essential information in English
    Alerts about reimbursement developments are sent to email every 2 weeks. For each news, a title, brief summary and the link are provided. You can follow the link to investigate the development further. Every new newsletter covers the last two weeks
  • Reports are developed using a manual search
    We do not trust search robots to identify and classify relevant information. The search and categorization of identified reports is performed manually by MTRC analysts
  • Both general and technology-specific news are included
    The service captures both general (e.g., the release of the next year DRG system) and technology-specific (e.g., coverage decision for transcatheter aortic valve implantation) news

Types of news included
  • 1
    Procedure codes
    New procedure codes (quarterly in Denmark, monthly private codes in England, annual codes in other countries)
  • 2
    DRG and reimbursement codes
    New DRGs, new add-on reimbursement categories. New out-patient reimbursement codes
  • 3
    Structural changes of the system
    New stakeholders, new conceptual legislation
  • 4
    Innovation funding
    New projects in the innovation funding schemes, developments of the programs, alerts about calls for proposals
  • 5
    Coverage decisions
    Coverage decisions by payors (e.g. NHS England) and decision-makers (e.g. Federal Joint Committee, Dutch Healthcare Institute)
  • 6
    Clinical practice guidelines
    Clinical guidelines, developed by the governmental organizations (e.g. HAS in France, Health Directorate in Norway)

Why use "Reimbursement Alerts"?
  • Timely access to essential information
    You can be the first to know about important developments for technology within the company and with your competition. Reimbursement decisions reveal new opportunities for your company's business
  • Ability to engage with reimbursement stakeholders
    By knowing about reimbursement development (e.g. consultation about new policy), you can engage with payors and decision-makers in a timely manner to give feedback on developments
  • Cost-effective approach
    No single Med Tech company can afford such a massive screening and monitoring activity. You outsource an essential function of keeping the company up-to-date at a modest cost. You can save both time and money with an external reimbursement monitoring service. Both quarterly and annual payments are possible
  • Customized information in a user-friendly format
    You only get access to reimbursement information for countries (e.g., EMEA only) and technologies (e.g., peripheral vascular + all general news) of relevance to your position. Newsletters are easy to navigate and easy to distribute internally
  • Suitable for both middle-size companies and large corporations
    The service is suitable for both middle-size companies with 1-2 people in the market access function and large corporations. For small companies, the service is the only opportunity to keep track of significant developments, and for large corporations, it complements the internal effort
  • More professional fulfillment of the market access role
    Market access professionals use all modern tools at their disposal to execute their function professionally. "Reimbursement Alerts" is becoming a new industry standard and essential tool in the portfolio of market access specialists

A service from a well-known partner
40%
of top-30 Med Tech companies trust MTRC subscription services
154 clients
received support from MTRC over the last three years
19 countries
where MTRC provides regular consulting services
700+ projects
were accomplished since 2017

Examples of decision-making on the basis of our alerts

Contact us to learn more and to get three-month, free, no-obligation trial

About MTRC
A specialized Med Tech reimbursement consultancy
17 out of top-30 global Med Tech companies routinely use reimbursement services of MTRC

Coverage of 19 European markets with consulting services

>130 reimbursement projects per year

15 full-time employees, located in six European countries. In-house coverage of key languages (French, German, Italian, Spanish, Polish, Russian, Turkish)

ISO 9001:2015 certified with the United Kingdom Accreditation Service, UKAS

Main web-sites: Med Tech, Online school in market access